scoliosis
发表于 2025-3-26 23:52:52
http://reply.papertrans.cn/43/4244/424306/424306_31.png
Inertia
发表于 2025-3-27 04:12:56
http://reply.papertrans.cn/43/4244/424306/424306_32.png
laxative
发表于 2025-3-27 06:57:21
http://reply.papertrans.cn/43/4244/424306/424306_33.png
漫不经心
发表于 2025-3-27 09:51:00
0075-8434 Overview: 978-3-540-13339-1978-3-540-38868-5Series ISSN 0075-8434 Series E-ISSN 1617-9692
ETHER
发表于 2025-3-27 14:53:50
http://reply.papertrans.cn/43/4244/424306/424306_35.png
无能性
发表于 2025-3-27 19:42:54
Jürgen JostD20 monoclonal antibody rituximab (R) to conventional chemotherapy has dramatically improved event-free survival (EFS) and overall survival (OS) in DLBCL , a significant proportion of patients are refractory or relapse following first-line treatment.
craving
发表于 2025-3-28 01:57:31
Jürgen JostD20 monoclonal antibody rituximab (R) to conventional chemotherapy has dramatically improved event-free survival (EFS) and overall survival (OS) in DLBCL , a significant proportion of patients are refractory or relapse following first-line treatment.